iBio, Inc.
IBIO
$2.22
$0.115.21%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -57.22% | -10.79% | -- | -- | -9.40% |
| Total Depreciation and Amortization | -16.61% | -1.37% | -- | -- | 1.08% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 821.69% | 19.43% | -- | -- | 16.41% |
| Change in Net Operating Assets | 249.72% | -6,712.50% | -- | -- | 38.25% |
| Cash from Operations | 7.48% | -22.75% | -- | -- | -4.15% |
| Capital Expenditure | -1,512.50% | -3,100.00% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 88.50% | -46,754.35% | -- | -- | -100.14% |
| Cash from Investing | 86.12% | -47,862.22% | -- | -- | -100.28% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -283.75% | 12.57% | -- | -- | -2.41% |
| Issuance of Common Stock | 1,026.85% | -86.56% | -- | -- | 350.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -87.65% | 681.94% | -- | -- | -- |
| Cash from Financing | -81.19% | 470.97% | -- | -- | 6.17% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -97.13% | 441.47% | -- | -- | -27.15% |